Independent Predictors of Steatohepatitis and Fibrosis in Asian Indian Patients with Non-Alcoholic Steatohepatitis

被引:0
|
作者
Deepak Kumar Singh
Puja Sakhuja
Veena Malhotra
Ranjana Gondal
Shiv Kumar Sarin
机构
[1] Govind Ballabh Pant Hospital,Department of Pathology
[2] Govind Ballabh Pant Hospital,Department of Gastroenterology
来源
关键词
Asian-Indian; Liver; NASH; Non-alcoholic steatohepatitis; Predictors;
D O I
暂无
中图分类号
学科分类号
摘要
Aim To identify the clinical and biochemical predictors of histologic disease severity in patients with non-alcoholic steatohepatitis (NASH). Method Clinical, anthropometric and biochemical data of 71 consecutive patients with a histological diagnosis of NASH were retrieved from the medical database. The histologic criteria proposed at the American Association for the Study of Liver Diseases Conference (2003) were followed. Histologic features and the necro-inflammatory grade of liver biopsy were scored in accordance with the Brunt score. Statistical analysis was performed to identify predictors of disease severity. Results The male to female ratio of the study cohort was 3.1:1. The mean body mass index (BMI) of the patients was 25.67 ± 1.9 kg/m2. In terms of necroinflammatory grading, 21 (29.6%) patients were classified as grade 1, 26 (36.6%) as grade 2 and 24 (33.8%) as grade 3. Multivariate analysis revealed that BMI (P = 0.009), waist circumference (P = 0.035), waist:hip ratio (P = 0.011) and aspartate aminotransferase levels (P < 0.001) were independent predictors of necroinflammatory grade and that female gender (P = 0.02), serum alkaline phosphatase levels (P = 0.018), cholesterol levels (P = 0.048) and low-density lipoprotein (LDL) levels (P = 0.025) were independent predictors of fibrosis stage. Conclusion Female gender, BMI, waist:hip ratio, hypercholesterolemia and LDL levels are independent predictors of disease severity in patients with NASH and may influence the decision to biopsy.
引用
收藏
页码:1967 / 1976
页数:9
相关论文
共 50 条
  • [21] Non-alcoholic steatohepatitis
    Saibara, T
    Onishi, S
    Ogawa, T
    Yoshida, S
    Enzan, H
    LANCET, 1999, 354 (9186): : 1299 - 1300
  • [22] Non-alcoholic steatohepatitis
    Petit, P
    Zarski, JP
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2000, 24 (02): : 157 - 159
  • [23] Non-alcoholic steatohepatitis
    Brierley, Rob
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (06): : 379 - 379
  • [24] Liraglutide for patients with non-alcoholic steatohepatitis
    Dale, Aaron
    Hartley, Philip
    Heneghan, Carl
    LANCET, 2016, 387 (10036): : 2378 - 2378
  • [25] ADIPONECTIN IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS
    Rusu, Emilia
    Enache, Georgiana
    Jinga, Mariana
    Dragut, Ramona
    Nan, Raluca
    Parpala, Cristina
    Popescu, H.
    Homentcovschi, Corina
    Ateia, Simona
    Posea, Mihalea
    Stoian, Marilena
    Costache, A.
    Rusu, F.
    Jinga, V.
    Mischianu, D.
    Radulian, Gabriela
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2015, 119 (03): : 664 - 669
  • [26] HBV infection may sensitize patients to alcoholic steatohepatitis and non-alcoholic steatohepatitis
    Wang, Hua
    GASTROENTEROLOGY REPORT, 2023, 12
  • [27] Predictors of non-alcoholic steatohepatitis (NASH) in overweight children
    不详
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2005, 41 (04): : 562 - 562
  • [28] Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
    Lee, Kuei-Chua
    Wu, Pei-Shan
    Lin, Han-Chieh
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (01) : 77 - 98
  • [29] Molecular Mechanisms of Hepatic Fibrosis in Non-Alcoholic Steatohepatitis
    Rombouts, Krista
    Marra, Fabio
    DIGESTIVE DISEASES, 2010, 28 (01) : 229 - 235
  • [30] Review article: the pathogenesis of fibrosis in non-alcoholic steatohepatitis
    Marra, F
    Aleffi, S
    Bertolani, C
    Petrai, I
    Vizzutti, F
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 : 44 - 47